These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1362840)

  • 1. Efficacy and skeletal side effects of two years' acitretin treatment.
    Mørk NJ; Kolbenstvedt A; Austad J
    Acta Derm Venereol; 1992 Nov; 72(6):445-8. PubMed ID: 1362840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology.
    Ormerod AD; Campalani E; Goodfield MJ;
    Br J Dermatol; 2010 May; 162(5):952-63. PubMed ID: 20423353
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of congenital ichthyosis with acitretin: a case report.
    Cakmak A; Baba F; Cakmak S; Shermatov K; Karazeybek H
    Minerva Pediatr; 2010 Dec; 62(6):599-603. PubMed ID: 21042273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adverse effect profile of acitretin in a pediatric dermatology population-Longitudinal cohort study and recommendations for monitoring.
    Cave A; Plumptre I; Mellerio JE; Martinez AE; Kinsler VA
    J Am Acad Dermatol; 2020 Dec; 83(6):1779-1781. PubMed ID: 32246970
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study.
    Verfaille CJ; Vanhoutte FP; Blanchet-Bardon C; van Steensel MA; Steijlen PM
    Br J Dermatol; 2007 May; 156(5):965-73. PubMed ID: 17263800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and side effects of acitretin on the disorders of keratinization: a one-year study.
    Kullavanijaya P; Kulthanan K
    J Dermatol; 1993 Aug; 20(8):501-6. PubMed ID: 8245313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal side-effects of 5 years' acitretin treatment.
    Mørk NJ; Kolbenstvedt A; Austad J
    Br J Dermatol; 1996 Jun; 134(6):1156-7. PubMed ID: 8763451
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of acitretin on the liver.
    Roenigk HH; Callen JP; Guzzo CA; Katz HI; Lowe N; Madison K; Nigra T; Fiedler VC; Armstrong RB
    J Am Acad Dermatol; 1999 Oct; 41(4):584-8. PubMed ID: 10495381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acitretin Use in Dermatology.
    Guenther LC; Kunynetz R; Lynde CW; Sibbald RG; Toole J; Vender R; Zip C
    J Cutan Med Surg; 2017; 21(3_suppl):2S-12S. PubMed ID: 28952335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
    Dogra S; Jain A; Kanwar AJ
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose acitretin in treatment of plaque-type psoriasis: descriptive study of efficacy and safety.
    Borghi A; Corazza M; Bertoldi AM; Caroppo F; Virgili A
    Acta Derm Venereol; 2015 Mar; 95(3):332-6. PubMed ID: 24978351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
    Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
    Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroderma in a patient taking acitretin for plaque psoriasis.
    Ahdout J; Mandel H; Chiu M
    J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature.
    Patel V; Sun G; Dickman M; Khuu P; Teng JM
    Dermatol Ther; 2015; 28(2):89-93. PubMed ID: 25546246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.
    Pang ML; Murase JE; Koo J
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):953-64. PubMed ID: 18624682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acitretin in the symptomatic therapy for severe recessive x-linked ichthyosis.
    Bruckner-Tuderman L; Sigg C; Geiger JM; Gilardi S
    Arch Dermatol; 1988 Apr; 124(4):529-32. PubMed ID: 2965549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.